[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ding et al., 2017 - Google Patents

MicroRNAs and cardiovascular disease in diabetes mellitus

Ding et al., 2017

View PDF @Full View
Document ID
2425325537030195671
Author
Ding Y
Sun X
Shan P
Publication year
Publication venue
BioMed research international

External Links

Snippet

Cardiovascular disease (CVD) is the major macrovascular complication of diabetes mellitus. Recently, although CVD morbidity and mortality have decreased as a result of comprehensive control of CVD risk factors, CVD remains the leading cause of death of …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Similar Documents

Publication Publication Date Title
Ding et al. MicroRNAs and cardiovascular disease in diabetes mellitus
de Lucia et al. microRNA in cardiovascular aging and age-related cardiovascular diseases
Williams et al. Are microRNAs true sensors of ageing and cellular senescence?
Surina et al. miR-21 in human cardiomyopathies
Ballantyne et al. Smooth muscle enriched long noncoding RNA (SMILR) regulates cell proliferation
Huang et al. A new insight into the roles of MiRNAs in metabolic syndrome
Price et al. Relevance of microRNA in metabolic diseases
Leung et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells
Menghini et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1
Alvarez et al. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression
Wronska et al. Application of micro RNA s in diagnosis and treatment of cardiovascular disease
Engin MicroRNA and adipogenesis
Raitoharju et al. MicroRNAs in the atherosclerotic plaque
Chen et al. MiR‐320a contributes to atherogenesis by augmenting multiple risk factors and down‐regulating SRF
Dentelli et al. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression
Caporali et al. Deregulation of microRNA-503 contributes to diabetes mellitus–induced impairment of endothelial function and reparative angiogenesis after limb ischemia
Wang et al. MiR‐195‐5p promotes cardiomyocyte hypertrophy by targeting MFN2 and FBXW7
Lin et al. Function, role, and clinical application of microRNAs in vascular aging
Jamaluddin et al. miRNAs: roles and clinical applications in vascular disease
León et al. Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives
Rome Are extracellular microRNAs involved in type 2 diabetes and related pathologies?
Araldi et al. MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases
Zhang et al. Circulating MicroRNAs: biogenesis and clinical significance in acute myocardial infarction
Wang et al. miRNA for diagnosis and clinical implications of human hepatocellular carcinoma
Ali Sheikh et al. Diagnostic, prognostic, and therapeutic value of circulating miRNAs in heart failure patients associated with oxidative stress